Zhang Y, Li X, Li S, Yang Z, et al. Alternating Oxaliplatin and Irinotecan Chemotherapy Combined With Capecitabine and Bevacizumab for Microsatellite-stable Stage IV Metastatic Colon Cancer With a BRAF V600E Mutation: Two Case Reports Indicating Survival Improvement over Standard Therap Anticancer Res 2025;45:399-404.
PMID: 39740847